Shares of bioMerieux (OTCMKTS:BMXMF – Get Free Report) gapped up prior to trading on Monday . The stock had previously closed at $122.79, but opened at $129.2550. bioMerieux shares last traded at $129.2550, with a volume of 25 shares trading hands.
bioMerieux Price Performance
The company’s 50-day simple moving average is $125.83 and its 200 day simple moving average is $135.02. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.27 and a quick ratio of 1.30.
bioMerieux Company Profile
bioMérieux is a global leader in in vitro diagnostics, specializing in the development, manufacture and distribution of diagnostic solutions that determine the source of disease and contamination to improve patient health and ensure consumer safety. The company’s product portfolio encompasses a broad range of assays and instruments for microbiological and immunoassay testing, including molecular diagnostics for infectious diseases, immunoassays for autoimmune and oncology markers, and traditional microbial identification and antimicrobial susceptibility testing.
Further Reading
- Five stocks we like better than bioMerieux
- Do not delete, read immediately
- How the Rich Retire
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- How Long Will $1M Last in Retirement?
- [No Brainer Gold Play]: “Show me a better investment.”
Receive News & Ratings for bioMerieux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioMerieux and related companies with MarketBeat.com's FREE daily email newsletter.
